08 - 10 April, 2025 | Berlin
Conference Day One
8:30 am - 8:55 am
NETWORKING BREAKFAST
8:55 am - 9:15 am
WELCOME FROM PHARMA IQ & SPEED NETWORKING
Maik Talarczyk -
Head, PMO ESO,
Sandoz
We begin this year’s Pharma Contract Manufacturing Summit with two very simple questions:
(1) What are the fundamental challenges we need to see addressed at this year’s event?
(2) Who do have in the room to help solve those problems?
Using speed networking, you will gain a clear sense of the industry makeup we have in the room and the issues we want to address together, leaving no stone unturned to get the answers you need
9:15 am - 9:45 am
MAKING THE RELATIONSHIP WORK: ASSESSING CONTEMPORARY CHALLENGES IN COLLABORATING EFFECTIVELY TO ENSURE THE EFFICIENT PRODUCTION OF HIGH-QUALITY PRODUCTS
Maik Talarczyk -
Head, PMO ESO,
Sandoz
Carlo Capobianco - Global Head ESO MS&T Launch Global Head ESO MS&T Launch, Sandoz
MAKING THE RELATIONSHIP WORK
This is what we will talk and present:
- SANDOZ: Who & Why we are after spin off from Novartis OCT 2023; Core EBITDA improvement targets
- Eso Network COmplexity Reduction – Challenges in generic Pharma Supplier Management with >350 FDF supplier and ways to drive complexity reduction
- Ensuring Quality & Competitiveness: How supplier complexity reduction drive down cost pressures without compromising product quality?
9:45 am - 10:30 am
CHARTING THE EVOLUTION OF CMO SELECTION CRITERIA & ITS IMPACT ON OUR ABILITY TO IDENTIFY & COLLABORATE WITH THE RIGHT PARTNERS
Daniel Hurni -
Director Strategy and Business Operations,
Bristol Myers Squibb
David Adoutte - Global Industrial, Purchasing & Supply Chain Director, Laboratoires Théa
Marco Badiali - Head of Contract Manufacturing Operations, Angelini
David Buhmann - VP, Head of Procurement Finished Goods, Bayer
How are we to go about making the crucial decision about who we partner with? In this next panel discussion we ask how you can achieve the depth of knowledge required to select not only a reliable partner, but the right partner who meets a range of criteria.
Core focus areas to include:
- Aligning Goals & Expectations Ensuring that your goals are aligned is essential. But how do you achieve this level of transparency early on? What are the deeper level questions that need answering?
- Values & Culture: How can you discern whether a potential CMO is aligned with your goals and objectives and fully committed to delivering on what you need
- What Your Product Needs: You need a partner who appreciates the specificity & uniqueness of your product – and can deliver it to a high standard. What does this synergy look like in practice?
- Evolving Criteria: How is the hierarchy of selection criteria evolving and how can you identify those partners who have the agility and flexibility to respond?
10:30 am - 11:00 am
GOING AFTER THE WIN-WIN: ALIGNING OUR PROCESSES, VALUES & GOALS TO SET UP OUR RELATIONSHIPS FOR LONG-TERM SUCCESS
Patrick Frey -
Head of B2B,
Acino
How can you ensure the partnership gets off on the right foot? In this next keynote, we explore how to shape the relationship in the early stages so that it works in the mutual interest of both parties.
Core focus areas to include:
- Leveraging expectations
- Price pressure in generic market vs increased manufacturing costs
- Constrained supply chains (product availability and long term lead time)
- Adoption of legal clauses to changing environments
11:00 am - 11:30 am
MORNING REFRESHMENT BREAK
11:30 am - 1:00 pm
ROUNDTABLE DISCUSSION GROUPS I BENCHMARKING NEW APPROACHES IN PHARMA CONTRACT MANUFACTURING
Philip Coetzee -
Director Contract Manufacturing Organization Management,
Daiichi Sankyo Europe GmbH
Olaf Peter Birkenmeier - Head External Manufacturing, Polpharma Biologics
Simone Kunze - Supplier Relationship Manager External Supply Organization, Sandoz
Laure Bovet - External Manufacturing Operations Lead Bio DS, UCB
Matthias Horn - External Manufacturing Manager, Bayer
Tero Virtanen - Sourcing Manager, Orion Corporation
How does it work? Choose a 60-minute discussion on a pressing topic. Interact with your peers, identifying contemporary challenges and novel approaches to confronting them. Each roundtable is led by a subject matter expert. A 30-minute feedback session will follow the discussions, where the roundtable leaders will share the key findings with the audience.
Topics to be covered are:
- CAN WE CONTINUE TO DRIVE DOWN COSTS WITHOUT COMPROMISING QUALITY?
- IN WHAT WAYS CAN WE IMPROVE DATA SHARING WITH EXTERNAL PARTNERS?
- HOW CAN WE COLLABORATE WITH PARTNERS TO MITIGATE ENVIRONMENTAL IMPACTS?
- WHAT ARE THE KEY CONSIDERATIONS FOR ACHIEVING A SUCCESSFUL TECH TRANSFER?
- WHAT CAN YOU DO TO REPAIR & IMPROVE A PARTNERSHIP THAT IS IN TROUBLE?
- CAN CMO PROCESS AUTOMATION IMPROVE COLLABORATION AND EFFICIENCY?
Philip Coetzee
Director Contract Manufacturing Organization ManagementDaiichi Sankyo Europe GmbH
1:00 pm - 2:00 pm
NETWORKING LUNCH
2:00 pm - 2:30 pm
PRACTICAL APPROACHES TO SUCCESSFUL PARTNERING: NEW PERSPECTIVES ON HOW TO ENSURE AN EFFICIENT & EFFECTIVE COLLABORATION WITH YOUR EXTERNAL PARTNERS
Kaisa Kallio -
External Manufacturing Manager,
Orion Pharma
You’ve selected a partner. You’ve shaped how you expect the collaboration will work. But now you need to make that happen. In this next keynote, we delve down into the fundamentals of good partnership working. How can we ensure that innovation and collaboration are one of the same thing?
Core focus areas to include:
- Combined Skills Deliver Greater Value: Be clear on what is needed from both sides and develop a practical plan for how you will continuously evolve the relationship moving forward
- Take Ownership as a Team: Move away from an internal/external mindset, incorporating your partners objectives and aligning them with into a shared mission
- Delivering Greater Transparency: What are the practical approaches for achieving greater transparency – not only in the way you communicate, but in the way you share data? How can technology enable this?
- Collaboration is Innovation: How has a more effective way of working impacted the future way of working? What are the implications for business improvement and product quality?
2:30 pm - 3:00 pm
IN FOCUS: THE COMMUNICATION CURE - MASTERING BETTER PARTNERSHIPS
Olaf Peter Birkenmeier -
Head External Manufacturing,
Polpharma Biologics
In this session, we explore the often-overlooked, yet vital ingredient in successful CMO partnerships: communication. It's the bridge between expectations and results, the translator of complex processes, and the secret that fuels trust and innovation.
Key Takeaways:
- Embrace the "Open Mic" Policy: Encourage open communication at all levels, from scientists to executives. Foster a culture where questions are welcomed, feedback is valued, and everyone feels empowered to contribute.
- Technology is Your Ally: Utilize communication platforms that facilitate real-time updates, transparent data sharing, and seamless collaboration across teams and locations.
- Invest in Relationships: Communication is a two-way street. Invest in building strong relationships with your CMO partner. Regular face-to-face meetings, team-building activities, and even casual coffee chats can go a long way in fostering trust and understanding.
3:00 pm - 3:30 pm
AFTERNOON REFRESHMENTS
3:30 pm - 4:30 pm
INTERACTIVE POLLING SESSION
Maik Talarczyk -
Head, PMO ESO,
Sandoz
4:30 pm - 5:30 pm
THE BIG QUESTION: HOW IS RISING OPERATIONAL COMPLEXITY & UNCERTAINTY IMPACTING OUR LONG-TERM DECISION-MAKING IN PHARMA CONTRACT MANUFACTURING
Kaisa Kallio -
External Manufacturing Manager,
Orion Pharma
Daniel Hurni - Director Strategy and Business Operations, Bristol Myers Squibb
How is rising operational complexity & uncertainty impacting our long-term decision-making in pharma contract manufacturing? In this concluding session, we ask how the macro-economic environment and geo-political situation are impacting not only our ability to achieve our goals but also our decisions and where and who to partner with.
Core focus areas to include:
- The Future Outlook: How are we to incorporate geo-politics in our decision-making, weighing up the pros and cons of partnering with particular regions of the world?
- Risk Mitigation Strategies: We explore what ‘cost-effective risk-mitigation’ means in-practice. How can you make the argument for investing more to offset risk?
- The Evolution of Risk: Discover how evolving regulatory factors, such as environmental impact mitigation, are changing the way in which we need to define operational risk
- Implications for Partner Localities: Is there now a greater emphasis on the locality of a potential partner due to operational complexity and uncertainty on a global scale?
